NCT03595124

A Study to Compare Treatments for a Type of Kidney Cancer Called TFE/Translocation Renal Cell Carcinoma (tRCC)

RecruitingPHASE2INTERVENTIONAL

Trial Details

Start: 2019-01-08Est. Completion: 2024-09-30

Enrollment target: 15 participants

Locations

Children's Hospital of Alabama, Birmingham, Alabama, United States
CTCA at Western Regional Medical Center, Goodyear, Arizona, United States
Cancer Center at Saint Joseph's, Phoenix, Arizona, United States
CHI Saint Vincent Cancer Center Hot Springs, Hot Springs, Arkansas, United States
Arkansas Children's Hospital, Little Rock, Arkansas, United States
Kaiser Permanente-Anaheim, Anaheim, California, United States
Mission Hope Medical Oncology - Arroyo Grande, Arroyo Grande, California, United States
PCR Oncology, Arroyo Grande, California, United States
Kaiser Permanente-Bellflower, Bellflower, California, United States
Mercy Cancer Center - Carmichael, Carmichael, California, United States
Mercy San Juan Medical Center, Carmichael, California, United States
Kaiser Permanente Downey Medical Center, Downey, California, United States
Mercy Cancer Center - Elk Grove, Elk Grove, California, United States
Kaiser Permanente-Fontana, Fontana, California, United States
Kaiser Permanente Los Angeles Medical Center, Los Angeles, California, United States

Other microbiome trials you might be interested in

CD70-Targeted Immuno-PET/CT-Directed Free of Therapy Used for mccRCC Patients With IMDC Favorable or Intermediate RiskPhase 2Recruiting

Metastatic Clear Cell Renal Cell Carcinoma

The purpose of this study is to evaluate the safety and feasibility of a treatment holiday strategy directed by CD70-tar…

Nanjing, ChinaEst. completion Aug 10, 2028

View Trial →

Immunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant Recipients With Unresectable or Metastatic Skin CancerPhase 1Recruiting

Clinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage III Cutaneous Merkel Cell Carcinoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8Clinical Stage IV Cutaneous Merkel Cell Carcinoma AJCC v8Metastatic Basal Cell Carcinoma

Apply or Learn More on ClinicalTrials.gov

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.